Cigogne Management Sa Poseida Therapeutics, Inc. Put Options Transaction History

Cigogne Management Sa

  • $169 Billion
  • Q4 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding PSTX

# of Institutions
5
Shares Held
5.34M
Call Options Held
0
Put Options Held
0
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $815M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Cigogne Management Sa Portfolio

Follow Cigogne Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigogne Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Cigogne Management Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email